bpc 157 ban FDA panel votes to loosen restrictions for controversial peptides FDA Advisers Vote to Ease

The peptide derives from a portion of a protein called Body Protection Compound, naturally found in human gastric juice

Available: [8] Hudson Biotech, A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Pentadecapeptide BPC 157 for Accelerated Repair of Acute Grade II Hamstring Strain Confirmed by MRI, clinicaltrials.gov, Clinical trial registration NCT07437547, Feb

The naturally occurring parent protein sits in the stomach environment in low concentrations and acts locally in the stomach

FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list The vote is non-binding and still needs sign-off from the FDA